Patient advocate and author | Canada
At 29 years old, Benjamin was diagnosed with Parkinson’s disease. He spent the next couple of years traveling the world visiting research centers and pharmaceutical companies to learn from the top minds in the field all that he could about this disease and what therapies were on the horizon. He has since become actively involved in neurodegenerative research and advocacy. He is the founder of Tomorrow Edition, where he has interviewed close to 80 experts in Parkinson’s disease. He sits on several patient advisory boards and speaks and consults regularly at academic labs, as well as biotech and pharmaceutical companies around the world.